Cryoport (CYRX) Common Equity (2011 - 2026)

Cryoport (CYRX) has reported Common Equity for 16 consecutive years, with $490.7 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Common Equity fell 5.47% year-over-year to $490.7 million in Q2 2026; TTM through Jun 2026 was $490.7 million, a 5.47% decrease from a year earlier, with the FY2025 full-year figure at $502.6 million, up 25.07% from the prior year.
• Common Equity was $490.7 million for Q2 2026 at Cryoport, down from $495.0 million in the prior quarter.
• Over five years, Common Equity peaked at $609.4 million in Q1 2022 and troughed at $398.8 million in Q1 2025.
• A 5-year average of $501.8 million and a median of $508.0 million in 2025 frame the typical range for Common Equity.
• Across the five-year window, Common Equity decreased 26.49% in 2024 and climbed 29.74% in 2025, its largest moves.
• Over 5 years, Common Equity stood at $555.8 million in 2022, then decreased by 12.02% to $489.0 million in 2023, then declined by 17.82% to $401.9 million in 2024, then grew by 25.07% to $502.6 million in 2025, then slipped by 2.38% to $490.7 million in 2026.
• The last three Common Equity figures came in at $490.7 million (Q2 2026), $495.0 million (Q1 2026), and $502.6 million (Q4 2025), per Business Quant data.